SCHEMBL13480222

SCHEMBL13480222

CCN(CC)CCN(CC)C(=O)c1c[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 11/20 0.67
KDR P35968 10/20 0.59
PDGFRB P09619 6/20 0.59
PRKAA1 Q13131 5/20 0.59
PRKAA2 P54646 4/20 0.59
CSF1R P07333 3/20 0.59
KIT P10721 3/20 0.59
PLK4 O00444 2/20 0.59
DCLK1 O15075 2/20 0.59
PDPK1 O15530 2/20 0.59
DAPK3 O43293 2/20 0.59
ROCK2 O75116 2/20 0.59
RPS6KA5 O75582 2/20 0.59
RPS6KA4 O75676 2/20 0.59
MAP4K4 O95819 2/20 0.59
CHEK2 O96017 2/20 0.59
NTRK1 P04629 2/20 0.59
INSR P06213 2/20 0.59
LCK P06239 2/20 0.59
FYN P06241 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12602180 0.85 KDR (0.73) FLT3KDRPDGFRBPRKAA1PRKAA2
SCHEMBL13480262 0.83 KDR (0.65) FLT3KDRPDGFRBPRKAA1PRKAA2
SCHEMBL29911476 0.81 AKT2 (0.69) FLT3KDRPDGFRBCSF1RKIT
SCHEMBL22917527 0.81 AKT2 (0.69) FLT3KDRPDGFRBCSF1RKIT
SCHEMBL28523144 0.80 FLT3 (1.00) FLT3KDRPDGFRBPRKAA1PRKAA2
SCHEMBL19862518 0.80 KDR (0.71) FLT3KDRPDGFRBPRKAA1PRKAA2
SCHEMBL29539755 0.80 AKT2 (0.62) FLT3KDRPDGFRBCSF1RALK
SCHEMBL15459745 0.79 KDR (0.74) FLT3KDRPDGFRBPRKAA1PRKAA2
SCHEMBL28430169 0.79 KDR (0.74) FLT3KDRPDGFRBPRKAA1PRKAA2
SCHEMBL28540205 0.78 FLT3 (0.85) FLT3KDRPDGFRBPRKAA1PRKAA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2157093-A1 PYRROLO-NITROGENOUS HETEROCYCLIC DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF Shanghai Hengrui Pharmaceutical Co. Ltd. (CN) 2010-02-24 EP disclosed